Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?
The cryopyrin-associated periodic syndromes (CAPS) are usually caused by heterozygous <i>NLRP3</i> gene variants, resulting in excessive inflammasome activation with subsequent overproduction of interleukin (IL)-1β. The CAPS spectrum includes mild, moderate, and severe phenotypes. The mi...
Main Authors: | Tatjana Welzel, Jasmin B. Kuemmerle-Deschner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/1/128 |
Similar Items
-
EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01) -
A unique presentation of NLRP3-associated autoinflammatory disease: case report
by: Stéphanie Ducharme-Bénard, et al.
Published: (2022-12-01) -
Síndrome CINCA: um diagnóstico diferencial da artrite idiopática juvenil CINCA syndrome: a differential diagnosis of the juvenile idiopathic arthritis
by: Erica Naomi Naka, et al.
Published: (2007-08-01) -
Clinical characteristics of Chinese neonates with neonatal-onset multisystem inflammatory disease: a case report and literature review
by: Cui Zhao, et al.
Published: (2024-01-01) -
Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome
by: Toshihiko Matsuo, et al.
Published: (2021-12-01)